HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tyrosine receptor kinase A Ig2

a synthetic recombinant NGF sequestering protein

Also Known As:

REN1820; trkA Ig2

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Allen, Shelley J: 1 article (03/2005)
2.	Dattilio, Abbey: 1 article (03/2005)
3.	Dawbarn, David: 1 article (03/2005)
4.	Hu, Vivian Y: 1 article (03/2005)
5.	Redman, Travis L: 1 article (03/2005)
6.	Stroemer, R Paul: 1 article (03/2005)
7.	Vizzard, Margaret A: 1 article (03/2005)
8.	Zvara, Peter: 1 article (03/2005)
9.	Dawbarn, D: 1 article (11/2001)
10.	Djouhri, L: 1 article (11/2001)

Related Diseases

1.	Cystitis 03/01/2005 - "Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis." 03/01/2005 - "These studies demonstrate that the use of the NGF sequestering protein REN1820 in rats with CYP induced cystitis decreases bladder overactivity. "
2.	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/01/2005 - "REN1820 may prove to be a novel therapeutic in individuals with the chronic inflammatory bladder syndrome interstitial cystitis."
3.	Inflammation (Inflammations) 11/15/2001 - "The nerve growth factor (NGF) dependence of the inflammation-induced changes was examined by injecting a synthetic NGF sequestering protein [tyrosine receptor kinase A Ig2 (trkA Ig2)] with CFA and subsequently into the CFA injection sites. "

Related Drugs and Biologics

1.	Nerve Growth Factor (NGF)
2.	Proteins (Proteins, Gene)
3.	tyrosine receptor kinase A Ig2
4.	Cyclophosphamide (Cytoxan)